FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892112010> ?p ?o ?g. }

• W2892112010 endingPage "1578" @default.
• W2892112010 startingPage "1568" @default.
• W2892112010 abstract "Objective In this secondary analysis of the Clusterbusters ® Medication Use survey, the use, effectiveness, and tolerability of inhaled oxygen were investigated and compared with injectable sumatriptan. We also sought to understand the predictors of medication response. Background Inhaled oxygen is a mainstay abortive intervention in cluster headache but is not approved by the Food and Drug Administration (FDA). Unlike injectable sumatriptan, the only FDA‐approved pharmacologic intervention for cluster headache, oxygen can be used multiple times a day, which is highly relevant for a condition with numerous daily attacks. In addition to obstacles in obtaining oxygen therapy, optimal oxygen delivery (ie, mask, flow rate) is not uniformly employed in cluster headache. These factors lead to underuse and imprecise therapeutic response rates. Methods A secondary analysis was conducted using deidentified data from the Clusterbusters ® Medication Use survey, which was modeled after previously published surveys and available online. Subjects were recruited from headache clinics and cluster headache websites. Most responses were chosen from a list; others were free‐texted. The final analysis included responses from 493 adult participants with a validated diagnosis of cluster headache. This analysis of deidentified data from the Clusterbusters ® Medication Use survey received institutional approval. Results The most commonly used delivery system used by subjects was a non‐rebreather‐type mask. The use of oxygen flow rates >10 L/min was a positive predictor of medication response (OR = 2.36, P = .016). Among those who used flow rates >10 L/min, both inhaled oxygen (81.5%) and injectable sumatriptan (80.5%) were efficacious and did not differ significantly from each other in any specific group examined. At flow rates >10 L/min, positive predictors of oxygen response were male gender (OR = 2.07, P = .031) and cigarette smoking (current or historical; OR = 2.25, P = .017). Among the groups examined, there were no predictors of sumatriptan response. Most comments about side effects and concerns were directed at triptans. Conclusion Therapeutic response to inhaled oxygen at sufficiently high flow rates (>10 L/min) had comparable efficacy to that of injectable sumatriptan for the acute treatment of cluster headache. Other factors in oxygen delivery (ie, flow rate changes) should be explored for optimization of therapy. The reasons for improved oxygen response in males and those with a cigarette smoking history require further exploration. While both oxygen and sumatriptan can be effective in the management of cluster headache, patient‐reported side effects and concerns were more commonly directed at triptan medications. Current restrictions on access to inhaled oxygen, which exist at many levels, limit the therapeutic options available for patients with cluster headache, thereby doing a disservice to this patient population and the providers who deliver their care." @default.
• W2892112010 created "2018-09-27" @default.
• W2892112010 creator A5007724162 @default.
• W2892112010 creator A5016882920 @default.
• W2892112010 creator A5023659439 @default.
• W2892112010 creator A5056238262 @default.
• W2892112010 creator A5056904977 @default.
• W2892112010 creator A5058933465 @default.
• W2892112010 date "2018-09-17" @default.
• W2892112010 modified "2023-09-25" @default.
• W2892112010 title "Survey Analysis of the Use, Effectiveness, and Patient-Reported Tolerability of Inhaled Oxygen Compared With Injectable Sumatriptan for the Acute Treatment of Cluster Headache" @default.
• W2892112010 cites W1545409067 @default.
• W2892112010 cites W1568040247 @default.
• W2892112010 cites W1889790357 @default.
• W2892112010 cites W1938763172 @default.
• W2892112010 cites W1964130465 @default.
• W2892112010 cites W1976768683 @default.
• W2892112010 cites W1984050552 @default.
• W2892112010 cites W1991191376 @default.
• W2892112010 cites W1996081907 @default.
• W2892112010 cites W2004649872 @default.
• W2892112010 cites W2006279628 @default.
• W2892112010 cites W2009076168 @default.
• W2892112010 cites W2017135359 @default.
• W2892112010 cites W2024059800 @default.
• W2892112010 cites W2037110937 @default.
• W2892112010 cites W2038759626 @default.
• W2892112010 cites W2043314967 @default.
• W2892112010 cites W2048592244 @default.
• W2892112010 cites W2049361602 @default.
• W2892112010 cites W2064338131 @default.
• W2892112010 cites W2075796856 @default.
• W2892112010 cites W2076402267 @default.
• W2892112010 cites W2083821823 @default.
• W2892112010 cites W2084139115 @default.
• W2892112010 cites W2090076425 @default.
• W2892112010 cites W2094713596 @default.
• W2892112010 cites W2104870824 @default.
• W2892112010 cites W2106411156 @default.
• W2892112010 cites W2109473644 @default.
• W2892112010 cites W2113578575 @default.
• W2892112010 cites W2121872045 @default.
• W2892112010 cites W2126363638 @default.
• W2892112010 cites W2132899918 @default.
• W2892112010 cites W2135664461 @default.
• W2892112010 cites W2149250228 @default.
• W2892112010 cites W2149837984 @default.
• W2892112010 cites W2151820652 @default.
• W2892112010 cites W2192859497 @default.
• W2892112010 cites W2273672020 @default.
• W2892112010 cites W2304169055 @default.
• W2892112010 cites W2483415541 @default.
• W2892112010 cites W2487203327 @default.
• W2892112010 cites W2555288948 @default.
• W2892112010 cites W2748753862 @default.
• W2892112010 cites W2752472348 @default.
• W2892112010 cites W2768876632 @default.
• W2892112010 cites W2769724041 @default.
• W2892112010 cites W2791157236 @default.
• W2892112010 cites W4241832729 @default.
• W2892112010 doi "https://doi.org/10.1111/head.13405" @default.
• W2892112010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30221765" @default.
• W2892112010 hasPublicationYear "2018" @default.
• W2892112010 type Work @default.
• W2892112010 sameAs 2892112010 @default.
• W2892112010 citedByCount "15" @default.
• W2892112010 countsByYear W28921120102019 @default.
• W2892112010 countsByYear W28921120102020 @default.
• W2892112010 countsByYear W28921120102021 @default.
• W2892112010 countsByYear W28921120102022 @default.
• W2892112010 countsByYear W28921120102023 @default.
• W2892112010 crossrefType "journal-article" @default.
• W2892112010 hasAuthorship W2892112010A5007724162 @default.
• W2892112010 hasAuthorship W2892112010A5016882920 @default.
• W2892112010 hasAuthorship W2892112010A5023659439 @default.
• W2892112010 hasAuthorship W2892112010A5056238262 @default.
• W2892112010 hasAuthorship W2892112010A5056904977 @default.
• W2892112010 hasAuthorship W2892112010A5058933465 @default.
• W2892112010 hasConcept C126322002 @default.
• W2892112010 hasConcept C164866538 @default.
• W2892112010 hasConcept C170493617 @default.
• W2892112010 hasConcept C1862650 @default.
• W2892112010 hasConcept C194828623 @default.
• W2892112010 hasConcept C197934379 @default.
• W2892112010 hasConcept C199360897 @default.
• W2892112010 hasConcept C2777942821 @default.
• W2892112010 hasConcept C2778375690 @default.
• W2892112010 hasConcept C2778541695 @default.
• W2892112010 hasConcept C2778871607 @default.
• W2892112010 hasConcept C2778938600 @default.
• W2892112010 hasConcept C2780630273 @default.
• W2892112010 hasConcept C41008148 @default.
• W2892112010 hasConcept C42219234 @default.
• W2892112010 hasConcept C71924100 @default.
• W2892112010 hasConceptScore W2892112010C126322002 @default.
• W2892112010 hasConceptScore W2892112010C164866538 @default.
• W2892112010 hasConceptScore W2892112010C170493617 @default.
• W2892112010 hasConceptScore W2892112010C1862650 @default.

• next